SURGICAL OUTCOMES IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA AFTER NEOADJUVANT CHEMOTHERAPY AND FIDUCIAL TARGETED IGRT: AN INSTITUTIONAL EXPERIENCE

被引：0
|
作者：
Sharma, Manav
Singh, Shailendra
Rao, Bharat
Kirichenko, Alexander
Morrissey, Suzanne
Mitre, Marcia
Garg, Mrinal
Kumar, Ujjala
Kulkarni, Abhijit
Monga, Dulabh
Schiffman, Suzanne
Williams, Harry K.
Atkinson, Donald
Lupetin, Anthony
Dhawan, Manish
Thakkar, Shyam
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31222-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1324
引用
收藏
页码：S276 / S277
页数：2
相关论文
共 50 条
  • [21] Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy
    Addeo, Pietro
    Rosso, Edoardo
    Fuchshuber, Pascal
    Oussoultzoglou, Elie
    De Blasi, Vito
    Simone, Gael
    Belletier, Christine
    Dufour, Patrick
    Bachellier, Philippe
    ONCOLOGY, 2015, 89 (01) : 37 - 46
  • [22] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Yuki Homma
    Koichi Taniguchi
    Takashi Murakami
    Kazuya Nakagawa
    Masatoshi Nakazawa
    Ryusei Matsuyama
    Ryutaro Mori
    Kazuhisa Takeda
    Michio Ueda
    Yasushi Ichikawa
    Kuniya Tanaka
    Itaru Endo
    Annals of Surgical Oncology, 2014, 21 : 670 - 676
  • [23] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [24] Outcomes of neoadjuvant chemotherapy with FOLFOX/FOLFIRINOX and chemoradiotherapy in borderline resectable pancreatic cancer: Single-institution experience
    Son, Chang O.
    Pai, Sachin Gopalkrishn
    Satti, Suma
    Dornelles, Adriana
    Bolton, John S.
    Conway, W. Charles
    Fuloria, Jyotsna
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [25] Surgical Resection Following Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer: Redefining the Standards
    Sandini, M.
    Marchegiani, G.
    Maggino, L.
    Viviani, E.
    Montresor, A.
    Binco, A.
    Malleo, G.
    Salvia, R.
    Bassi, C.
    PANCREAS, 2016, 45 (10) : 1536 - 1536
  • [26] Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients
    Botta, Gregory P.
    Huynh, Tridu R.
    Spierling-Bagsic, Samantha R.
    Agelidis, Alexander
    Schaffer, Randolph
    Lin, Ray
    Sigal, Darren
    CANCER MEDICINE, 2023, 12 (07): : 7713 - 7723
  • [27] Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy
    Engineer, R.
    Pathare, P.
    Bhandare, M.
    Krishnatry, R.
    Gudi, S.
    Ostwal, V.
    Ramaswamy, A.
    Shrikhande, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E437 - E438
  • [28] Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Kumamoto, Kensuke
    Suzuki, Yasuyuki
    Okano, Keiichi
    HPB, 2023, 25 (01) : 136 - 145
  • [29] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Javed, Ammar A.
    Wright, Michael J.
    Siddique, Ayat
    Blair, Alex B.
    Ding, Ding
    Burkhart, Richard A.
    Makary, Martin
    Cameron, John L.
    Narang, Amol
    Herman, Joseph
    Zheng, Lei
    Laheru, Daniel
    Weiss, Matthew J.
    Wolfgang, Christopher
    He, Jin
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (01) : 112 - 121
  • [30] OUTCOME OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER IN THE CONTEMPORARY ERA OF NEOADJUVANT CHEMOTHERAPY
    Javed, Ammar A.
    Siddique, Ayat
    Blair, Alex
    Parish, Lindsay
    Burkhart, Richard
    Weiss, Matthew J.
    Cameron, John
    Narang, Amol
    Zheng, Lei
    Laheru, Daniel
    Wolfgang, Christopher L.
    He, Jin
    GASTROENTEROLOGY, 2018, 154 (06) : S1265 - S1265
12345